Navigate to Other Instruments
JAZZJazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
JAZZKey Takeaways
Last updated: 2026-08-10- •The $1.32B Jazz-Actio deal is UNCONFIRMED by primary sources — official announcement required before high-conviction positioning.
- •Jazz's recent M&A track record (Chimerix at $944M, GW Pharma in 2021) makes a deal of this scale entirely plausible and strategically consistent.
- •Acquirer stocks (JAZZ) typically face short-term selling pressure on announcement; the real trade may be in comparable rare-disease biotech names repriced by takeout speculation.
- •Sector-level impact is modestly bullish for clinical-stage biotech and healthcare ETFs as M&A premiums get re-rated across the space.
- •Monitor deal structure (cash vs. debt mix) and implied premium on Actio's pipeline — these will determine whether the market views the acquisition as value-accretive or dilutive.
Price & Market Structure
Trading Regime Status
Glossary
Key listed-stock and CFD terms, one line each — so the page is unambiguous for both readers and AI answer engines.
| Stock CFD | A contract for difference on a share price — price exposure only, not ownership of the underlying shares. |
|---|---|
| Extended hours | Pre-market and after-hours trading outside the exchange’s regular session. |
| Basis risk | The risk that the CFD reference price and the exchange execution price do not move in step. |
| P/E | Price-to-earnings ratio = share price ÷ earnings per share; a common valuation gauge. |
| Gross margin | Gross profit ÷ revenue; reflects product-level profitability. |
| EPS | Earnings per share = net income ÷ diluted shares outstanding. |
Latest Pulses
Jazz Pharmaceuticals Eyes $1.32B Actio Biosciences Deal — What Traders Need to Know
Reports indicate that Jazz Pharmaceuticals (NASDAQ: JAZZ) is pursuing an acquisition of Actio Biosciences in a deal valued at approximately $1.32 billion. Important caveat: our research verification f
Jazz Pharmaceuticals Posts Record Q1 2026 Revenue, Smashes EPS Estimates as Zanidatamab Approval Looms
Jazz Pharmaceuticals (NASDAQ: JAZZ) delivered a landmark Q1 2026 earnings report on May 5, 2026, reporting total revenue of $1.07B–$1.1B — a 19% year-over-year increase that surpassed analyst consensu
Get Started with Jazz Pharmaceuticals plc
Start trading Jazz Pharmaceuticals plc on CoinUnited.io with industry-leading leverage and fees that drop to 0% at the top VIP tier.
Trade with Leverage
Trade JAZZ CFDs with up to 1000x leverage on CoinUnited.io.
- Up to 1000x leverage
- Fees down to 0%
- Advanced risk management tools
Explore Stocks
Browse the full stocks market on CoinUnited.io with 125+ instruments.
- 125+ stocks instruments
- Real-time market data
- Professional charting tools
Learn Stocks Trading
Read our in-depth research and analysis on stocks markets.
- Expert market analysis
- Technical analysis basics
- Daily market insights
How to Trade Jazz Pharmaceuticals plc: Step-by-Step Guide
Learn how to trade Jazz Pharmaceuticals plc (JAZZ) on CoinUnited.io with up to 1000x leverageand volume-tiered fees that reach 0% at the top VIP level. Follow this simple step-by-step guide to start CFD trading today.
Create Your CoinUnited.io Account
Sign up at CoinUnited.io in under a minute. You'll need an email address to get started.
- ✓Quick and free registration
- ✓Email and password setup
- ✓Two-factor authentication for security
Verify Your Identity
Complete the KYC verification process to unlock full trading features and higher limits.
- ✓Upload government-issued ID
- ✓Proof of address document
- ✓Usually verified within minutes
Deposit Funds
Fund your account using one of the supported deposit methods.
Deposit Methods
- •Cryptocurrency deposits (BTC, ETH, USDT)
- •Bank transfer available
- •No minimum deposit requirement
Find JAZZ in the Stocks Section
Navigate to the stocks market section and search for JAZZ. You can trade Jazz Pharmaceuticals plc as a CFD with up to 1000x leverage.
- ✓Search for "JAZZ" in the trading platform
- ✓Select CFD trading mode
- ✓Review the current price and market data
Place Your Trade
Choose your position direction (long or short), set your leverage, and enter your position size to trade Jazz Pharmaceuticals plc.
- ✓Long (buy) if you expect JAZZ to rise
- ✓Short (sell) if you expect JAZZ to fall
- ✓Set stop-loss and take-profit levels
Monitor & Manage Risk
Keep track of your open positions and manage risk with stop-loss orders and position sizing.
- ✓Monitor P&L in real-time
- ✓Adjust stop-loss as needed
- ✓Never risk more than you can afford to lose
Order Types
Market Order
Execute immediately at the current market price. Best for quick entries.
Limit Order
Set a specific price to enter. The order fills only when the market reaches your price.
Stop-Loss Order
Automatically close your position at a specified price to limit potential losses.
Important Tips
- • Start with a small position to understand how leverage works
- • Always set a stop-loss to protect your capital
- • Higher leverage amplifies both gains and losses
- • Never invest more than you can afford to lose
Tags
Frequently Asked Questions
Jazz Pharmaceuticals plc is a stocks instrument available for trading on CoinUnited.io.
Disclaimers & References
Important Risk Disclaimer
A CoinUnited stock CFD gives price exposure to Jazz Pharmaceuticals plc only, not equity ownership: no shareholder voting rights, no dividends, and no settlement in the underlying share.
Leverage magnifies losses as well as gains, and a position can be liquidated long before the underlying share price recovers. The underlying listing trades on exchange hours, so the reference price can gap between sessions.
Users should conduct their own research and consult with qualified financial professionals before making any investment decisions. The creators and operators of this platform assume no responsibility for any financial losses or other damages that may result from reliance on the information provided.
Leveraged trading is extremely risky and you may lose your entire deposit.
Methodology Overview
Figures on this page are compiled from primary and named third-party sources, not produced by a forecasting model. Each one carries its source and date in the Source Map above.
- Financial statements: the company's own SEC filings (10-K / 10-Q), read from XBRL
- Market data: the CoinUnited reference price and daily closes
- Institutional ownership: SEC Form 13F quarterly filings
- Analyst targets: aggregated third-party sell-side coverage — third-party opinion, not CoinUnited's view
- Peer multiples: third-party trailing-twelve-month ratios
CoinUnited does not publish a price forecast or target for Jazz Pharmaceuticals plc.
Last methodology review:
Ready to Start Trading Jazz Pharmaceuticals plc?
Join thousands of traders and start your Jazz Pharmaceuticals plc trading journey today. Get access to advanced trading tools and competitive fees.